Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version 2 (2019-06-11) updates the study record with a Recruitment Status change. This reflects a new enrollment status for the EARLY trial (NCT03750760).
    Difference
    0.1%
    Check dated 2025-11-03T01:20:21.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    13%
    Check dated 2025-10-05T10:29:22.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T03:23:09.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2; the Back to Top element has been removed.
    Difference
    0.8%
    Check dated 2025-09-13T17:43:58.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.8%
    Check dated 2025-09-06T15:26:50.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has undergone significant changes with the addition of a facility name and location, while several location-related terms and details have been removed.
    Difference
    6%
    Check dated 2025-08-30T12:08:15.000Z thumbnail image

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.